Fetal DNA test could reduce invasive procedures

Published



A new test detecting fetal DNA in a mother?s blood could reduce invasive procedures, such as amniocentesis and removal of tissue from the uterus, to predict birth defects.

In “A Non-invasive Test for Prenatal Diagnosis Based on Fetal DNA Present in Maternal Blood: A Preliminary Study,” published in The Lancet online, Johns Hopkins School of Nursing student Kara Franz and colleagues describe their work isolating fetal DNA to diagnose chromosomal abnormalities.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.